GI Biome, an affiliate of GI Innovation, is embarking on a collaborative research and development initiative with Progen for the creation of a next-generation anti-obesity treatment.

On the 25th, GI Biome, specializing in microbiome research, announced the signing of an MOU with Progen. As per the agreement, the two companies will jointly conduct research on the combination of Progen's candidate substances for obesity treatment and GI Biome's microbiome targeting anti-obesity and metabolic disorder.

Read more: https://n.news.naver.com/mnews/article/015/0004872152?sid=105